Date of Graduation

5-2025

Document Type

Dissertation

Degree Name

Doctor of Philosophy in Chemistry (PhD)

Degree Level

Graduate

Department

Chemistry & Biochemistry

Advisor/Mentor

Sakon, Joshua

Committee Member

Thallapuranam, Suresh

Second Committee Member

Millet, Francis S.

Third Committee Member

Archer, Crystal

Fourth Committee Member

Kim, Jin-Woo

Keywords

Collagen; Collagenase; Mechanism; NMR; SAXS; X-ray crystallography

Abstract

In biological systems, Hathewaya (Clostridium) histolytica secretes collagenases that degrade structural collagen in host tissues and cause tissue necrosis. Despite their detrimental effects, these enzymes have significant therapeutic potential by effectively digesting various collagen subtypes to treat connective tissue disorders. The bacterium produces two homologous collagenases, ColG and ColH, with a catalytic module crucial for hydrolyzing collagen and binding domains, including collagen-binding domains (CBDs) and polycystic kidney disease-like domains (PKDs), for substrate interaction.

Although the crystal structure of the catalytic module of collagenase G (ColG) has been determined, shedding light on its chew-and-digest mechanism, the structure of collagenase H (ColH) remains unknown, limiting a deeper understanding of its catalytic mechanism. In this study, the structure of the ColH catalytic module was resolved in an unprecedented “closed” conformation using X-ray crystallography. Heteronuclear Single Quantum Coherence (HSQC) Nuclear Magnetic Resonance (NMR) spectroscopy further elucidated how ColH recognizes and unwinds collagen triple helix for endopeptidase activity. Small-angle X-ray scattering (SAXS) demonstrated how ColH binds to mini-collagen to feed the catalytic module with the substrate for digestion. Together, these findings provide a comprehensive understanding of ColH’s role in collagen degradation, which would help develop more effective therapeutic agents.

Also, a heparin-crosslinked membrane platform was developed for the large-scale purification of viral vectors. This platform can capture adeno-associated virus serotype 2 (AAV2) particles and release them on demand, which could be helpful for gene therapy applications.

Available for download on Wednesday, June 17, 2026

Included in

Chemistry Commons

Share

COinS